Last reviewed · How we verify
NCT06964399
The Effect of Reminiscence Therapy in Elderly
NA trial testing Reminiscence therapy in Age-related Cognitive Decline in 90 participants. Currently enrolling.
30 May 2025
Quick facts
| Lead sponsor | Muş Alparslan University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | single group |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 90 |
| Start date | 1 April 2025 |
| Primary completion | 30 May 2025 |
| Estimated completion | 30 June 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Reminiscence therapy
Conditions studied
- Age-related Cognitive Decline — all drugs for Age-related Cognitive Decline →
Sponsor
Muş Alparslan University
Who can join
Adults 65 to 100, any sex, with Age-related Cognitive Decline. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this study titled "Psychological Well-Being and Awareness in the Elderly: The Effect of Reminiscence Therapy", patients will be randomly divided into two groups as experimental and control groups. No intervention will be made to the patients in the control group. Reminiscence therapy will be applied to the patients in the experimental group. Participants will be asked to fill out the scale forms after accepting to participate in the study and obtaining their consent. In addition, after the reminiscence therapy is completed, the experimental and control groups will be asked to fill out the post-test forms. The following questions will be answered in the study; * Does reminiscence therapy affect the psychological well-being levels of the elderly? * Does reminiscence therapy affect the awareness levels of the elderly?
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06964399
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Reminiscence therapy
Trials testing the same drug.
- NCT06812442 — Effectiveness of a 3-month Individual Reminiscence Therapy Program in Older Adults With Alzheimer's Disease · NA · completed
- NCT06180694 — Reminiscence Therapy in Individuals With Dementia · NA · completed
- NCT07374887 — Impact of Snoezelen Intervention and Reminiscence Therapy on Seniors' Emotionality and Anxiety · NA · completed
- NCT05637177 — Preventive Intervention to Promote Healthy Ageing · NA · completed
- NCT04658394 — Effect of Individual Reminiscence Therapy in the Elderly People With Neurocognitive Disorders · NA · completed
Other recruiting trials for Age-related Cognitive Decline
Currently open trials in the same condition.
- NCT06948136 — Acute Effects of THC in Older Adult · Phase 1 · recruiting
- NCT06893432 — Cognitive Function and EEG Brain Network Remodeling Among Users of Hearing Aids With ARHL · active not recruiting
- NCT06377254 — Multi-organ Responses to CHronic Physical Activity and INactivity · NA · recruiting
- NCT04184375 — Cognitive Stimulation for Elderly Bipolar Patients · NA · recruiting
- NCT04171323 — The Active Mind Trial: An Adaptive Randomized Trial to Improve Function and Delay Dementia · NA · recruiting
Other Muş Alparslan University trials
Trials by the same sponsor.
- NCT07507695 — Acute Effects of Patellar Tendon Ultrasound on Countermovement Jump Performance · NA · not yet recruiting
- NCT07297628 — Teaching Caring Through '1 Concept-1 Minute · NA · not yet recruiting
- NCT07397221 — Oropharyngeal Humidification After Extubation on Thirst · NA · not yet recruiting
- NCT07355244 — Self-Affirmation Intervention After Mastectomy · NA · not yet recruiting
- NCT07274553 — Mindfulness-Based Stress Reduction for Adolescents: Effects on Game Addiction, Stress, and Sleep · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06964399 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Muş Alparslan University
- Last refreshed: 9 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06964399.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing